Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RHYTHMIA HDx™ Mapping System

K-Number: K241227 · 2024-08-29

Decision Date2024-08-29
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

RHYTHMIA HDx™ Mapping System is a medical device manufactured by Boston Scientific Corporation. It received FDA 510(k) clearance on 2024-08-29 under approval number K241227. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RHYTHMIA HDx™ Mapping System?

RHYTHMIA HDx™ Mapping System is a medical device that received FDA 510(k) clearance on 2024-08-29. It is manufactured by Boston Scientific Corporation. The 510(k) number is K241227.

When was RHYTHMIA HDx™ Mapping System approved by the FDA?

RHYTHMIA HDx™ Mapping System received FDA 510(k) clearance on 2024-08-29, under approval number K241227.

What company makes RHYTHMIA HDx™ Mapping System?

RHYTHMIA HDx™ Mapping System is manufactured by Boston Scientific Corporation.

What is the FDA product code for RHYTHMIA HDx™ Mapping System?

The FDA product code for RHYTHMIA HDx™ Mapping System is DQK.

Related Clinical Trials

Other Devices by Boston Scientific Corporation

View all 176 devices →

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.